The application of both a chemical (diazoxide) and a peptide (KAE1-1) activator of PKCε effectively averted apoptosis caused by 5-Lox inhibition, reinforcing the idea that 5-Lox’s role in supporting pancreatic cancer cell survival operates through a PKCε-dependent pathway. The gene discussed is PRKCE; the disease is pancreatic neoplasm.